EnVVeno Medical Corporation (NASDAQ:NVNO) | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 06/21/2024 at 14:40, 5 months ago

Résultats intermédiaires positifs pour la VenoValve d'enVVeno Medical dans l'essai SAVVE

VenoValve Approbation De La FDA Essai SAVVE Ulcères Veineux
BRIEF

published on 06/21/2024 at 14:40, 5 months ago

Positive Interim Results for enVVeno Medical’s VenoValve in SAVVE Trial

FDA Approval VenoValve SAVVE Trial Venous Ulcers
PRESS RELEASE

published on 06/21/2024 at 14:35, 5 months ago

Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
Veno Medical Corporation presents positive interim data on VenoValve for venous ulcer healing at Society for Vascular Surgery meeting. Company aims for FDA approval in Q4 2024

FDA Approval VenoValve Venous Ulcers Veno Medical Corporation SAVVE U.S. Pivotal Trial
BRIEF

published on 06/17/2024 at 18:05, 5 months 4 days ago

De nouvelles données provisoires sur la guérison de l'ulcère veineux issues de l'essai enVVeno Medical VenoValve seront présentées au VAM2024

EnVVeno Medical VenoValve VAM2024 Ulcère Veineux Essai SAVVE
BRIEF

published on 06/17/2024 at 18:05, 5 months 4 days ago

New Interim Venous Ulcer Healing Data from enVVeno Medical VenoValve Trial to be Presented at VAM2024

EnVVeno Medical VenoValve SAVVE Trial Venous Ulcer VAM2024
PRESS RELEASE

published on 06/17/2024 at 18:00, 5 months 4 days ago

New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical Corporation to present new interim venous ulcer healing data from VenoValve U.S. trial at VAM2024. Study focuses on treatment of venous disease with innovative bioprosthetic solutions

VenoValve EnVVeno Medical Corporation Venous Disease SAVVE Study Vascular Annual Meeting 2024
BRIEF

published on 05/08/2024 at 20:45, 6 months 13 days ago

EnVVeno Medical publie des résultats prometteurs pour le premier trimestre 2024 et les prochains dépôts auprès de la FDA

EnVVeno Medical Équipement Médical Résultats Financiers Du Premier Trimestre 2024 VenoValve Approbation FDA Donnée Clinique
BRIEF

published on 05/08/2024 at 20:45, 6 months 13 days ago

EnVVeno Medical Reports Promising First Quarter 2024 Results and Upcoming FDA Filings

Medical Devices Clinical Data EnVVeno Medical Q1 2024 Financial Results VenoValve FDA Approval
PRESS RELEASE

published on 05/08/2024 at 20:40, 6 months 13 days ago

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported ending the quarter with $42.9 million cash and investments to fund operations through 2025, presenting positive data at the 46th Annual Charing Cross Symposium

Financial Results EnVVeno Medical Corporation SAVVE Trial Venous Disease VenoValve FDA Approval
BRIEF

published on 04/24/2024 at 12:20, 6 months 27 days ago

Améliorations cliniques significatives signalées dans l'essai pivot VenoValve d'enVVeno Medical

VenoValve Essai Clinique Approbation De La FDA Symposium De Charing Cross Maladie Veineuse

Accesswire

Published on 11/22/2024 at 00:00, 4 hours 18 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 6 hours 13 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 6 hours 28 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 8 hours 3 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 8 hours 8 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 9 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 9 hours 42 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 10 hours 20 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 10 hours 27 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 10 hours 27 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 21 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 20 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 8 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE